NCNA NuCana plc

Nasdaq nucana.com


$ 5.07 $ -0.07 (-1.36 %)    

Friday, 17-Oct-2025 19:45:20 EDT
QQQ $ 604.92 $ 3.94 (0.66 %)
DIA $ 461.73 $ 2.22 (0.48 %)
SPY $ 665.28 $ 3.75 (0.57 %)
TLT $ 91.09 $ -0.14 (-0.15 %)
GLD $ 391.28 $ -7.46 (-1.88 %)
$ 5.07
$ 5.01
$ 5.00 x 1,213
$ 5.50 x 2
$ 5.01 - $ 5.34
$ 2.78 - $ 400.00
175,160
na
3.6M
$ 1.27
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 nucana-publishes-nutide303-clinical-and-preclinical-data-on-nuc-3373-in-medrxiv-and-plos-one

NUC-3373 Plus Pembrolizumab Continues to Show Favorable Efficacy and Safety Profile in Heavily Pre-treated PatientsLatest Data ...

 nucana-cancels-all-remaining-series-a-warrants-after-raising-required-capital-eliminating-overhang-from-may-2025-offering

NuCana plc (NASDAQ:NCNA) ("NuCana" or the "Company") announces it has successfully canceled all remaining Serie...

 nucana-announces-1-for-200-ads-ratio-change-effective-august-8-2025

NuCana plc (NASDAQ:NCNA) ("NuCana" or the "Company") announced plans to change the ratio of its American Deposi...

 nucana-entered-into-sales-agreement-relating-to-sale-of-adss-offered-by-prospectus-supplement-may-offer-and-sell-adss-of-up-to-100m-from-time-to-time

- SEC Filing

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION